GIRO: Global Impact
of Radiotherapy in Oncology

ONE MILLION LIVES BY 2035

PURPOSE

We aim to save lives and improve quality of life of cancer patients through data-driven and evidence-based innovation in radiation oncology.

MISSION

Our mission is to reduce inequalities and ensure universal access to radiotherapy.

VALUES

We look for affordable, accessible and meaningful innovation; we seek for and support collaboration and partnership.

CALL TO ACTION:

GIRO, under the aegis of European Society for Radiotherapy and Oncology, is responding to the calls to action laid out in the report of the Global Task Force on Radiotherapy for Cancer Control (GTFRCC).

The GTFRCC, convened by the board of the Union for International Cancer Control (UICC), represented a collective effort of the radiotherapy community and provided a detailed analysis of the current situation worldwide.

GIRO is the next phase of this project: starting from this knowledge base, highlighting the importance of radiotherapy in cancer care, GIRO will provide answers on how to save lives by closing the gap in radiotherapy access.

GTFRCC ACTION ITEMS:

  • Incorporate radiotherapy into population-based cancer control plans in 80% of countries by 2020
  • Increase by 25% the 2015 radiotherapy treatment capacity by the year 2025
  • Train 7,500 radiation oncologists; 20,000 radiation technologists; and 6,000 medical physicists in LMICs by 2025
  • Invest $46 billion by 2025 to establish radiotherapy infrastructure and training in LMICs
  • Include radiotherapy services as part of the healthcare plans for universal health coverage in 80% of LMICs by 2020
LEARN MORE

OUR AIMS:

We want to widen the scope of existing projects that aim at closing the gap in access to radiotherapy.
To do so, GIRO will develop a platform of exchange in order to impact on the current situation of radiotherapy worldwide at various levels including:

ACCESS

RESOURCES

EDUCATION

REIMBURSEMENT

HEALTHCARE PLANNING